NKX2-1 and adenocarcinoma: Notably, simultaneous KrasG12D expression and Nkx2-1 inactivation induces mucinous-type lung adenocarcinomas, whereas KrasG12D expression alone induces only non-mucinous type lung adenoma/adenocarcinomas.